ASX - By Stock
|
CAN |
abc
|
|
ManChild001
|
0 |
203 |
1 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
0
|
203
|
1
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Application for quotation of securities - AGH
|
|
ManChild001
|
2 |
1.1K |
1 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Results of Share Purchase Plan Offer
|
|
ManChild001
|
12 |
7.7K |
2 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
12
|
7.7K
|
2
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ManChild001
|
50 |
19K |
2 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
50
|
19K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
2021 BRN Discussion
|
|
ManChild001
|
33K |
11M |
12 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
33K
|
11M
|
12
|
|
ASX - By Stock
|
BRN |
Re:
2021 BRN Discussion
|
|
ManChild001
|
33K |
11M |
9 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
33K
|
11M
|
9
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Althea Continues European Expansion Via Ireland Market Entry
|
|
ManChild001
|
21 |
8.4K |
0 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
21
|
8.4K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
ARM you a believer?
|
|
ManChild001
|
526 |
185K |
9 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
526
|
185K
|
9
|
|
ASX - By Stock
|
AGH |
Re:
Althea - time to buy?
|
|
ManChild001
|
84 |
47K |
2 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
84
|
47K
|
2
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ManChild001
|
8 |
4.0K |
4 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
8
|
4.0K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
10-20c Fall !
|
|
ManChild001
|
59 |
25K |
3 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
59
|
25K
|
3
|
|
ASX - By Stock
|
AGH |
Re:
Trend reversal
|
|
ManChild001
|
222 |
96K |
2 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
222
|
96K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
Intentionally Misleading Article Pinned to Top of Hotcopper
|
|
ManChild001
|
146 |
43K |
7 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
146
|
43K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
Biotome Partnership
|
|
ManChild001
|
180 |
68K |
3 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
180
|
68K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
60 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
60
|
|
ASX - By Stock
|
BRN |
Re:
Biotome Partnership
|
|
ManChild001
|
180 |
68K |
4 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
180
|
68K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
Biotome Partnership
|
|
ManChild001
|
180 |
68K |
18 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
180
|
68K
|
18
|
|
ASX - By Stock
|
BRN |
Re:
BRAINCHIP - Continues to IMPRESS the worldwide markets with it's NDA and ASX disclosures.
|
|
ManChild001
|
179 |
50K |
14 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
179
|
50K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Further US Patent Awarded
|
|
ManChild001
|
140 |
63K |
57 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
140
|
63K
|
57
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Further US Patent Awarded
|
|
ManChild001
|
140 |
63K |
71 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
140
|
63K
|
71
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
8 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
8
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
25 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
25
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
19 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
19
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
37 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
37
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
3 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
192
|
80K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
5 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
192
|
80K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
14 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
14
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
8 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
192
|
80K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
7 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
192
|
80K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
23 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
23
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
17 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
192
|
80K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
55 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
192
|
80K
|
55
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
17 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
192
|
80K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
73 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
73
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
69 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
69
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
11 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
11
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
31 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
31
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
17 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
17
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
27 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
27
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
16 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
192
|
80K
|
16
|
|
ASX - By Stock
|
BRN |
Re:
Australian Defence Force
|
|
ManChild001
|
119 |
47K |
14 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
119
|
47K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
9 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
9
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
36 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
192
|
80K
|
36
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
80 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
192
|
80K
|
80
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
47 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
47
|
|
ASX - By Stock
|
BRN |
Re:
QUALCOMM is worth watching
|
|
ManChild001
|
192 |
80K |
45 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
192
|
80K
|
45
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
ManChild001
|
1.0K |
429K |
4 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
1.0K
|
429K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
ManChild001
|
1.0K |
429K |
29 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
1.0K
|
429K
|
29
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
ManChild001
|
10K |
4.7M |
9 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
ManChild001
|
110 |
49K |
27 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
110
|
49K
|
27
|
|